SK Biopharmaceuticals (KRX: 326030)
OTHER
Seongnam, Gyeonggi, South Korea
SK Biopharmaceuticals is a corporation based in Seongnam-si, South Korea. Established in 1993, it develops drugs for central nervous system disorders and brain tumors. The company operates a BioScience Research Institute in Pangyo Techno Valley, Gyeonggi Province. Its drug pipeline includes Cenobamate, Solriamfetol, Carisbamate, Relenopride, SKL13865, SKL20540, SKL-PSY, and SKL24741. The assets are managed by the executive team.
Total Investments
0
Portfolio Companies
0
Exits
0
Funds
0
Investment Focus